Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T10:15:56.702Z Has data issue: false hasContentIssue false
  • English
  • Français

Significance of Positive and Negative Syndromes in Chronic Schizophrenia

Published online by Cambridge University Press:  29 January 2018

S. R. Kay ,
L. A. Opler  and
A. Fiszbein
S. R. Kay*
Affiliation:
Department of Psychiatry, Albert Einstein College of Medicine/Montefiore Medical Center, and Research and Assessment Unit, Bronx Psychiatric Center, 1500 Waters Place, Bronx, New York 10461, USA
L. A. Opler
Affiliation:
Department of Psychiatry, Albert Einstein College of Medicine/Montefiore Medical Center, and Research and Assessment Unit, Bronx Psychiatric Center, 1500 Waters Place, Bronx, New York 10461, USA
A. Fiszbein
Affiliation:
Department of Psychiatry, Albert Einstein College of Medicine/Montefiore Medical Center, and Research and Assessment Unit, Bronx Psychiatric Center, 1500 Waters Place, Bronx, New York 10461, USA
*
Correspondence
Get access Rights & Permissions [Opens in a new window]

Extract

Positive and negative syndromes were studied in relation to demographic, historical, genealogical, clinical, psychometric, extrapyramidal, and follow-up measures of 101 chronic schizophrenic patients. The criterion scales proved to be reliable, normally distributed, and strongly correlated with general psychopathology, but otherwise inversely related to one another. Multiple regression analysis identified sets of 4–6 independent variables that explained 74%-81 % of the scales' variance. A positive syndrome was associated chiefly with productive features, family history of sociopathy, more previous hospital admissions, and longer in-patient stay during the 30-month follow-up period. A negative syndrome correlated with deficits in cognitive, affective, social, and motor spheres, higher incidence of major psychiatric illness but less affective disorder among relatives, lower education, and greater cognitive developmental impairment. The results underscore the importance of genetic and biodevelopmental variables for understanding schizophrenic syndromes.

Type
Papers
Information
The British Journal of Psychiatry , Volume 149 , Issue 4 , October 1986 , pp. 439 - 448
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Allen, H. A. (1983) Do positive symptom and negative symptom subtypes of schizophrenia show qualitative differences in language production? Pyschological Medicine, 13, 787–797.CrossRefGoogle ScholarPubMed
Alpert, M., Diamond, F., Weisenfreund, J., Taleporos, E. & Friedhoff, A. J. (1978) The neuroleptic hypothesis: study of the covariation of the extrapyramidal and therapeutic drug effects. British Journal of Psychiatry, 133, 169–175.Google Scholar
Alpert, M., Diamond, F., Weisenfreund, J., Taleporos, E. & Rush, M. (1983) Comparison of affect in Parkinson's disease and schizophrenia. Psychopharmacology Bulletin, 19, 118–120.Google Scholar
American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd ed.) (DSM-III). Washington DC: APA.Google Scholar
Ammons, R. B. & Ammons, C. H. (1962) The Quick Test (QT): provisional manual. Psychological Reports, 11, 111–162.CrossRefGoogle Scholar
Andreasen, N. C. (1982) Negative symptoms in schizophrenia: definition and reliability. Archives of General Psychiatry, 39, 784–788.Google Scholar
Andreasen, N. C. & Olsen, S. (1982) Negative v positive schizophrenia: definition and validation. Archives of General Psychiatry, 39, 789–794.CrossRefGoogle ScholarPubMed
Andreasen, N. C., Dennert, J. W. & Smith, M. R. (1982) Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms. American Journal of Psychiatry, 139, 297–302.Google Scholar
Angrist, B., Rotrosen, J. & Gershon, S. (1980) Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology, 72, 17–19.Google Scholar
Aylward, E., Walker, E. & Bettes, B. (1984) Intelligence in schizophrenia: meta-analysis of the research. Schizophrenia Bulletin, 10, 430–459.Google Scholar
Blatt, S. J. (1959) Recall and recognition vocabulary: implications for intellectual deterioration. Archives of General Psychiatry, 1, 473–476.Google Scholar
Bleuler, E. (1911) Dementia Praecox or the Group of Schizophrenias. Translated by Zinkin, J. (1950). New York: International Universities Press.Google Scholar
Borison, R. (1984) The recognition and management of drug-induced movement disorders (reversible type). Presented at the 137th Annual Meeting of the American Psychiatric Association, Los Angeles, California, May 5–11, 1984.Google Scholar
Crow, T. J. (1980a) Molecular pathology of schizophrenia: more than one disease process? British Medical Journal, 280, 66–68.CrossRefGoogle ScholarPubMed
Crow, T. J. (1980b) Positive and negative schizophrenia symptoms and the role of dopamine. British Journal of Psychiatry, 137, 383–386.CrossRefGoogle ScholarPubMed
Feighner, J., Robins, E., Guze, S., Woodruff, R. A., Wjnokur, G. & Munoz, R. (1972) Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57–63.CrossRefGoogle ScholarPubMed
Ferguson, G. A. (1966) Statistical Analysis in Psychology and Education. New York: McGraw-Hill.Google Scholar
Gottesman, I. & Shields, J. (1976) A critical review of recent adoption, twin, and family studies of schizophrenia. Schizophrenia Bulletin, 2, 360–398.Google Scholar
Graham, F. K. & Kendall, B. S. (1960) Memory-for-Designs Test: revised general manual. Perceptual and Motor Skills, 11, 147–188.Google Scholar
Green, M. & Walker, E. (1984) Susceptibility to backward masking in schizophrenic patients with positive and negative symptoms. American Journal of Psychiatry, 141, 1273–1275.Google Scholar
Johnstone, H. C., Crow, T. J., Fermer, I. N., Frith, C. D., Owens, D. G. C, Bourne, R. C. & Gamble, S. J. (1983) Advene effects of anticholinergic medication on positive schizophrenic symptoms. Psychological Medicine. 13, 513–527.Google Scholar
Johnstone, H. C., Crow, T. J., Fermer, I. N., Frith, C. D., Owens, D. G. C., Bourne, R. C., Farm, C. D., Husband, J. A Kreel, L. (1976) Cerebral ventricular size and cognitive impairment in chronic schizophrenia. The Lancet, ii, 924–926.CrossRefGoogle ScholarPubMed
Johnstone, H. C., Crow, T. J., Fermer, I. N., Frith, C. D., Owens, D. G. C, Bourne, R. C., Carney, M. W. P. & Price, J. S. (1978a) Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. The |Lancet, 1, 848–851.CrossRefGoogle ScholarPubMed
Johnstone, H. C., Crow, T. J., Fermer, I. N., Frith, C. D., Owens, D. G. C, Bourne, R. C., Carney, M. W. P., Stevens, M., Kreel, L. & Husband, J. (1978b) The dementia of dementia praecox. Acta Psychlatrica Scandbiavica, 57, 305–324.Google Scholar
Kay, S. R. (1977) Developmental assessment of cognitive style in mentally retarded psychotics. Journal of Clinical Psychology, 33, 953–958.Google Scholar
Kay, S. R. (1980) Progressive figure drawings in the developmental assessment of mentally retarded psychotics. Perceptual and Motor Skills. 56, 583–590.Google Scholar
Kay, S. R. (1981) Arousal and schizophrenia: toward a dual-process model and framework for research. JSAS Catalog of Selected Documents in Psychology, 11, 35–36. (Manuscript no. 2256).Google Scholar
Kay, S. R. (1982) The Cognitive Diagnostic Battery: Evaluation of Intellectual Disorders. Odessa, Florida: Psychological Assessment Resources.Google Scholar
Kay, S. R. & Singh, M. M. (1974) A temporal measure of attention in schizophrenia and its clinical significance. British Journal of Psychiatry. 125, 146–151.Google Scholar
Kay, S. R. & Singh, M. M. (1975) A developmental approach to delineate components of cognitive dysfunction in schizophrenia. British Journal of Social and Clinical Psychology, 14, 387–399.CrossRefGoogle ScholarPubMed
Kay, S. R. & Singh, M. M. (1979) Cognitive abnormality in schizophrenia: a dual-process model. Biological Psychiatry, 14, 155–176.Google ScholarPubMed
Kay, S. R., & Smith, J. M. (1975) Colour Form Representation Test: a developmental method for the study of cognition in schizophrenia. British Journal of Social and Clinical Psychology, 14, 401–411.CrossRefGoogle Scholar
Kraepelin, E. (1913) Dementia Praecox and Paraphrenia. Translated by Barclay, R. M. Robertson, AG. M. (1971). New York: Robert E. Krieger.Google Scholar
Lindenmayer, J. P., Kay, S. R. & Opler, L. A. (1984) Positive and negative subtypes in acute schizophrenia. Comprehensive Psychiatry, 25, 455–464.Google Scholar
Marcus, J., Auerbach, J., Wilkinson, L. A Burack, C. M. (1981) Infants at high risk for schizophrenia: the Jerusalem infant developmental study. Archives of General Psychiatry, 38, 703–713.Google Scholar
National Institute of Mental Health (1974) Abnormal Involuntary Movement Scale (AIMS). Washington DC: Department of Health, Education, and Welfare.Google Scholar
Opler, L. A. A Kay, S. R. (1985) Birth seasonality and schizophrenia. Archives of General Psychiatry, 42, 107.Google Scholar
Rosado, V. A Lindenmayer, J. P. (1984) Positive and negative syndromes in chronic schizophrenic inpatients. Journal of Nervous and Mental Disease, 172, 317–325.Google Scholar
Overall, J. E. & Gorham, D. R. (1962) Brief psychiatric rating scale. Psychological Reports, 10, 799–812.Google Scholar
Parnas, J., Schulsinger, F., Schulsinger, H., Mednick, S. A. & Teasdale, T. W. (1982) Behavioral precursors of schizophrenic spectrum: a prospective study. Archives of General Psychiatry, 39, 658–664.Google Scholar
Puget, J. (1928) Judgement and Reasoning in the Child. New York: Harcourt Brace.Google Scholar
Pogue-Geile, M. F. & Harrow, M. (1984) Negative and positive symptoms in schizophrenia and depression: a follow-up. Schizophrenia Bulletin, 10, 371–387.Google Scholar
Ripkin, A., Quitrín, F. & Klein, D. F. (1975) Akinesia. Archives çf General Psychiatry, 32, 672–674.Google Scholar
Salierno, C. A., Evans, F. J. & Marcelo-Evans, B. J. (1984) Random number generation as an objective measure of clinical progress in emotionally disturbed adolescents. Proceedings and Abstracts of the Annual Meeting of the Eastern Psychological Association, 55, 80.Google Scholar
Schneider, K. (1959) Clinical Psychopathology. Translated by Hamilton, M. W. (1959). New York: Grune and Stratton.Google Scholar
Seidman, L. J. (1983) Schizophrenia and brian dysfunction: an integration of recent neurodiagnostic findings. Pyschohgical Bulletin, 94, 195–238.Google Scholar
Shakow, D. (1979) Adaptation in Schizophrenia: The Theory of Segmental Sets. New York: John Wiley and Sons.Google Scholar
Singh, M. M. & Kay, S. R. (1975) A comparative study of halopendol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophenia: theoretical implications for potency differences among neuroleptics. Psychopharmacologia, 43, 103–113.Google Scholar
Singh, M. M. & Kay, S. R. (1982) Toward a psychobiological model of schizophrenia: a clinical neuroscientist's view. In Psychobiology Schizophrenia (eds M. Namba & H. Kaiya). Oxford: Pergamon.Google Scholar
Van Putten, T. & May, P. R. A. (1978) “Akinetic depression” in schizophrenia. Archives of General Psychiatry. 35, 1101–1107.CrossRefGoogle Scholar
Walker, E. A Emory, E. (1983) Infants at risk for psychopathology: offspring of schizophrenic parents. Child Development, 54, 1269–1285.CrossRefGoogle ScholarPubMed
Weinberger, D. R. & Wyatt, R. J. (1983) Enlarged cerebral ventricles in schizophrenia. Psychiatric Annals, 13, 412–418.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.